Reva Raghupathi

Reva Raghupathi has over 25 years of experience in US and global marketing, business leadership, biomedical research and nonprofit enterprise. This includes Merck where she held roles as Executive Director, Diabetes Franchise, and Executive Director, Primary Care, In 2018, Reva founded Verika LLC, focused on developing solutions for social impact organizations and start-ups. In 2021, Reva joined Aarvik Therapeutics as Chief Business Officer, supporting Aarvik’s mission to develop powerful innovations in oncology therapeutics through tetravalent, multifunctional antibody platforms. At a community level, Reva serves as the Judge of Elections for her precinct. Reva’s academic qualifications include a PhD in medicinal chemistry from Virginia Commonwealth University and MBA in healthcare management and marketing from the Wharton School of the University of Pennsylvania, post-doctoral research in neuropharmacology at the University of Pennsylvania and medicinal chemistry at the University of Iowa. She received an MS in nonprofit leadership from the University of Pennsylvania in 2019.